A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH)

MLA

Palma Gámiz, Jose Luis, et al. “A Twelve-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Noninferiority Trial of the Antihypertensive Efficacy and Tolerability of Imidapril and Candesartan in Adult Patients with Mild to Moderate Essential Hypertension: The Iberian Multicenter Imidapril Study on Hypertension (IMISH).” Clinical Therapeutics, vol. 28, no. 12, Dec. 2006, pp. 2040–51. EBSCOhost, https://doi.org/10.1016/j.clinthera.2006.12.006.

APA

Palma Gámiz, J. L., Pêgo, M., Contreras, E. M., Anglada, M. P., Martinez, J. O., Esquerra, E. A., & Sagastagoitia Gorostiza, J. D. (2006). A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH). Clinical Therapeutics, 28(12), 2040–2051. https://doi.org/10.1016/j.clinthera.2006.12.006

Chicago

Palma Gámiz, Jose Luis, Mariano Pêgo, Emilio Márquez Contreras, Montserrat Pujol Anglada, Josefina Oliván Martinez, Eduardo Alegría Esquerra, and Jose Domingo Sagastagoitia Gorostiza. 2006. “A Twelve-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Noninferiority Trial of the Antihypertensive Efficacy and Tolerability of Imidapril and Candesartan in Adult Patients with Mild to Moderate Essential Hypertension: The Iberian Multicenter Imidapril Study on Hypertension (IMISH).” Clinical Therapeutics 28 (12): 2040–51. doi:10.1016/j.clinthera.2006.12.006.